Evidence map›Paper›PMID 36348260›Full record

ReviewHormones (Athens, Greece)2023

Addison's disease without hyperpigmentation in pediatrics: pointing towards specific causes.

Aristeidis Giannakopoulos, Amalia Sertedaki, Alexandra Efthymiadou, Dionisios Chrysis

Abstract readCase ReportsReview
PubMed Publisher
In one paragraph

Review in Hormones (Athens, Greece), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Addison's Disease: Diagnosis and Management Strategies.International journal of general medicine · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Aristeidis GiannakopoulosDivision of Pediatric Endocrinology, Department of Pediatrics, Medical School of Patras, University Hospital, 26504, Rio, Patras, Greece. argianak@upatras.gr.ORCID http://orcid.org/0000-0001-9730-5027
Amalia SertedakiDivision of Endocrinology, Diabetes and Metabolism, First Department of Pediatrics, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Alexandra EfthymiadouDivision of Pediatric Endocrinology, Department of Pediatrics, Medical School of Patras, University Hospital, 26504, Rio, Patras, Greece.
Dionisios ChrysisDivision of Pediatric Endocrinology, Department of Pediatrics, Medical School of Patras, University Hospital, 26504, Rio, Patras, Greece.
General University Hospital of Patras · GRNational and Kapodistrian University of Athens · GRUniversity of Patras · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionHyperpigmentation of skin and mucous membranes comprises a hallmark of the clinical diagnosis of Addison's disease. However, there have been reports of patients with adrenal insufficiency from diverse causes who did not develop hyperpigmentation. The pathophysiology responsible for the absence of increased pigmentation is not clearly defined in many cases. CASE PRESENTATION: We present a patient with isolated glucocorticoid deficiency due to two novel heterozygous variants in the sphingosine-1-phosphate lyase 1 (SPGL1) gene that did not develop any hyperpigmentation. DISCUSSION: We elaborate on the presumed mechanism of the absence of hyperpigmentation in adrenal insufficiency due to SPGL1 deficiency and discuss the other reported cases of Addison's disease without hyperpigmentation and the possible mechanism accounted for.

conclusionAbsence of hyperpigmentation, a basic component of the clinical diagnosis of Addison's disease, may lead to delay of a critical diagnosis, while causes that result in adrenal insufficiency without hyperpigmentation should explicitly be considered in pediatric cases where adrenal failure is documented by clinical symptomatology and biochemistry.

Indexed as

Addison DiseaseAdrenal InsufficiencyHyperpigmentationChildHumansSkinAbsence of hyperpigmentationAdrenal insufficiencyMetabolic diseaseSphingosine-1-phosphate lyase 1 deficiency

Identifiers

PMID36348260
OpenAlexW4308532229

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.